Differential response of human healthy lymphoblastoid and CCRF-SB leukemia cells to sulforaphane and its two analogues: 2-oxohexyl isothiocyanate and alyssin

Pharmacological Reports

Volumn 59, Issue 1, 2007, Pages 80-87

  Misiewicz, Irena ^a   Skupinska, Katarzyna ^a   Kasprzycka Guttman, Teresa ^a,b  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

^b UNIVERSITY OF WARSAW   (Poland)

Author keywords

2 oxohexyl isothiocyanate; Alyssin; Apoptosis; Chemoprevention; Isothiocyanates; Phase II enzymes; Sulforaphane

Indexed keywords

2 OXOHEXYL ISOTHIOCYANATE; ALYSSIN; GLUTATHIONE; ISOTHIOCYANIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SULFORAPHANE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER CELL CULTURE; CELL VIABILITY; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME INDUCTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOBLASTOID CELL;

EID: 34047191454     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Benhar M, Engelberg D, Levitzki A: ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep, 2002, 3, 420-425.
2. Brooks JD, Paton VG, Vidanes G: Potent induction of phase 2 enzymes in human prostate cells by sulforaphane. Cancer Epidemiol Biomark Prev, 2001, 10, 949-954.
3. Dinkova-Kostova AT, Holtzlaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, Talalay P: Direct evidence that sulfhydryl group of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA, 2002, 99, 11908-11913.
4. Fimognari C, Nusse M, Berti F, Iori R, Cantelli-Forti G, Hrelia P: Cyclin D3 and p53 mediate sulforaphane-induced cell cycle delay and apoptosis in non-transformed human T-lymphocytes. Cell Mol Life Sci, 2002, 59, 2004-2012.
5. Fimognari C, Nusse M, Cesari R, Iori R, Cantelli-Forti G, Hrelia P: Growth inhibition, cell cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis, 2002, 23, 581-586.
6. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N et al.: Sulforaphane, a naturally occuring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res, 2000, 60, 1426-1433.
7. Jiang ZQ, Chen C, Yang B, Hebbar V, Kong ANT: Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. Life Sci, 2003, 72, 2234-2253.
8. Kjær A: Naturally derived isothiocyanates (mustard oils) and their parent glucosides. Fortschr Chem Org Naturst, 1960, 18, 122-176.
9. Leoni O, Iori R, Palmieri S: Hydrolysis of glucosinolates using nylon-immobilized myrosinase to produce pure bioactive molecules. Biotechnol Bioeng, 2000, 68, 660-664.
10. Misiewicz I, Kozar A, Skupinska K, Kowalska E, Lubinski J, Kasprzycka-Guttman T: Inhibition of cell cycle and induction of apoptosis by sulforaphane in cell lines carrying various inherited BRCA1 mutations. Oncol Rep, 2005, 13, 659-665.
11. Misiewicz I, Skupinska K, Kasprzycka-Guttman T: Sulforaphane and 2-oxohexyl isothiocyanate induce cell growth arrest and apoptosis in L-1210 leukamia and ME-18 melanoma cells. Oncol Rep, 2003, 10, 2045-2050.
12. Misiewicz I, Skupinska K, Kowalska E, Lubinski J, Kasprzycka-Guttman T: Sulforaphane-mediated induction of a phase 2 detoxyfying enzyme NAD(P)H: quinone reductase and apoptosis in human lymphoblastoid cells. Acta Biochim Pol, 2004, 51, 711-721.
13. Petri N, Tannergren C, Holst B, Mellon FA, Bao Y, Plumb GW, Bacon J et al.: Absorption/metabolism of sulforaphane and quercitin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metab Disp, 2003, 31, 805-813.
14. Prochaska HJ, Santamaria AB: Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal Biochem, 1988, 169 328-336.
15. 2 in cultured endothelial cells. Arch Biochem Biophys, 1993, 302, 348-355.
16. Schmidt H, Karrer P: Synthese der racemischen und der optisch aktiven Formen des Sulforaphans. Helv Chim Acta, 1948, 31, 1497-1505.
17. Sebastia J, Cristofol R, Martin M, Rodriguez-Farre E, Sanfeliu C: Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytometry A, 2002, 51, 16-25.
18. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, Steele Jr GD, Chen LB: Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci USA, 1991, 88, 3671-3675.
19. Su B, Gu JQ, Kang YH, Park EJ, Pezzuto JM, Kinghorn AD: Induction of the phase II enzyme, quinone reductase, by withanolides and norwithanolides from solanaceous species. Mini-Rev Org Chem, 2004, 1, 115-123.
20. Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW: Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int J Oncol, 2004, 24, 187-192.
21. Ye L, Dinkova-Kostova AT, Wade KL, Zhang Y, Shapiro TA, Talalay P: Quantitive determination of dithiocarbamates in human plasma, serum and urine: pharmacokinetics of broccoli sprouts isothiocyanates in humans. Clin Chim. Acta, 2002, 316, 43-53.
22. Zhang Y, Kensler TW, Cho CG, Posner GH, Talalay P: Anticarcinogenic activities of sulforaphane and structurally related synthetic norbornyl isothiocyanates. Proc Natl Acad Sci USA, 1994, 91, 3147-3150.
23. Zhang Y, Talalay P, Cho CG. Posner GH: A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure. Proc Natl Acad Sci USA, 1992, 89, 2399-2403.
24. Zhang Y, Talalay P: Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res, 1998, 58, 4632-4639.
25. Zhang Y: Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis, 2001, 22, 425-431.